Thrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort Study

201924 citationsJournal Articlegreen Open Access

Authors

James E. Siegler · Hospital of the University of Pennsylvania

Steven R. Messé · Hospital of the University of Pennsylvania

Heidi Sucharew · Cincinnati Children's Hospital Medical Center

Scott E. Kasner · Hospital of the University of Pennsylvania

Tapan Mehta · Hennepin County Medical Center

Niraj Arora · Jackson Memorial Hospital

Amy Starosciak

Abstract

Thrombectomy is used in practice for some patients ineligible for the DAWN/DEFUSE-3 trials with potentially favorable outcomes. Additional trials are needed to confirm the safety and efficacy of thrombectomy in broader populations, such as large core infarction and M2 occlusions.

Topics & Keywords

Acute Ischemic Stroke Management Venous Thromboembolism Diagnosis and Management Intracerebral and Subarachnoid Hemorrhage Research

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Neurosurgery

Volume 86, Issue 2, pp. E156-E163

DOI: 10.1093/neuros/nyz485

Field-Weighted Citation Impact: 2.23